Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kramer

Showing results (561-570 of 613) with videos related to

Pageof 62
Sort By:
The Review of Scientific Instruments|December 3, 2022
System-on-chip approach microwave imaging reflectometer on DIII-D tokamakY Zhu, Y Chen, J-H Yu, et al.
Journal of Clinical Pharmacology|September 25, 2010
Safety, tolerability, and pharmacokinetics of eliglustat tartrate (Genz-112638) after single doses, multiple doses, and food in healthy volunteersM Judith Peterschmitt, Amy Burke, Larry Blankstein, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2023
Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy VolunteersMichael R Hodges, Eric Ople, Pamela Wedel, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 2, 2019
A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteersPaul M Karpecki, Sidney L Weiss, William G Kramer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteersRobert J Hopkins, William G Kramer, William C Blackwelder, et al.
Journal of Translational Medicine|November 24, 2016
A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenarioThais Bascuas, María Moreno, Amy Mónaco, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2001
Binding specificity of Escherichia coli trigger factorH Patzelt, S Rüdiger, D Brehmer, et al.
Journal of Dairy Science|July 20, 2007
Evaluating the conjugated linoleic acid and trans 18:1 isomers in milk fat of dairy cows fed increasing amounts of sunflower oil and a constant level of fish oilC Cruz-Hernandez, J K G Kramer, J J Kennelly, et al.
Steroids|March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomesEric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral loadVictor G Kramer, Susan M Schader, Maureen Oliveira, et al.
Pageof 62

Showing results (561-570 of 613) with videos related to

Sort By:
Pageof 62
The Review of Scientific Instruments|December 3, 2022
System-on-chip approach microwave imaging reflectometer on DIII-D tokamakY Zhu, Y Chen, J-H Yu, et al.
Journal of Clinical Pharmacology|September 25, 2010
Safety, tolerability, and pharmacokinetics of eliglustat tartrate (Genz-112638) after single doses, multiple doses, and food in healthy volunteersM Judith Peterschmitt, Amy Burke, Larry Blankstein, et al.
Antimicrobial Agents and Chemotherapy|March 29, 2023
Safety and Pharmacokinetics of Intravenous and Oral Fosmanogepix, a First-in-Class Antifungal Agent, in Healthy VolunteersMichael R Hodges, Eric Ople, Pamela Wedel, et al.
Clinical Ophthalmology (Auckland, N.Z.)|May 2, 2019
A phase 1, open-label, single-arm study evaluating the ocular safety of OTX-101 and systemic absorption of cyclosporine in healthy human volunteersPaul M Karpecki, Sidney L Weiss, William G Kramer, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 9, 2004
Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteersRobert J Hopkins, William G Kramer, William C Blackwelder, et al.
Journal of Translational Medicine|November 24, 2016
A novel non-Hodgkin lymphoma murine model closer to the standard clinical scenarioThais Bascuas, María Moreno, Amy Mónaco, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 29, 2001
Binding specificity of Escherichia coli trigger factorH Patzelt, S Rüdiger, D Brehmer, et al.
Journal of Dairy Science|July 20, 2007
Evaluating the conjugated linoleic acid and trans 18:1 isomers in milk fat of dairy cows fed increasing amounts of sunflower oil and a constant level of fish oilC Cruz-Hernandez, J K G Kramer, J J Kennelly, et al.
Steroids|March 11, 2018
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomesEric P Hoffman, Valerie Riddle, Maxime A Siegler, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2012
Maraviroc and other HIV-1 entry inhibitors exhibit a class-specific redistribution effect that results in increased extracellular viral loadVictor G Kramer, Susan M Schader, Maureen Oliveira, et al.
Pageof 62